Margarida Azevedo, MSc, — 
Margarida graduated with a BS in Health Sciences from the University of Lisbon and a MSc in Biotechnology from Instituto Superior Técnico (IST-UL). She worked as a molecular biologist research associate at a Cambridge UK-based biotech company that discovers and develops therapeutic, fully human monoclonal antibodies.
Articles by Margarida Azevedo
Recent Posts
- 8 Cases of aHUS Linked to Underlying, Complement-activating Conditions
- Blood Test May Help Diagnose TTP/aHUS in Pregnant Women, Study Finds
- NORD’s ‘Living Rare, Living Stronger’ Patient, Family Forum Set for June 26
- Genetic Testing IDs 2 Gene Mutations in Woman, 49, With Signs of aHUS
- Measuring ADAMTS13 Helps Differentiate aHUS From Similar Diseases in Report
- COVID-19 Spurs Onset of aHUS in Infants With Unusual EXOSC3 Mutation
- Delay in aHUS Diagnosis Linked to Woman’s Previous Cancer
- Organizations Rally to Help Ukrainian Rare Disease Patients
- Soliris Effective, Safe in aHUS Children in Real-world, Study Finds
- aHUS Diagnosed After Flu Vaccination